Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.
Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis.
Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth.
Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.
What Explains Gray Matter Atrophy in Long-standing Multiple Sclerosis?
ARESTIN®
[The membrane stabilizing effect of glatiramer acetate in multiple sclerosis].
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
Immune response during interferon beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse-free in the START study.
Brain Volume Loss during the First Year of Interferon-Beta Treatment: Baseline Inflammation and Tissue-Specific Volume Dynamics.
European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide)
4th Biannual NeuroUnit Biomarkers for Inflammation and Neurodegeneration Symposium on Biomarkers in Neurodegenerative Disease
Dose comparison trial of sustained-release fampridine in multiple sclerosis.
A novel pH-sensitive interferon-β (INF-β) oral delivery system for application in multiple sclerosis.
Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Alemtuzumab
Cladribine exerts an immunomodulatory effect on human and murine dendritic cells.
Federation of Clinical Immunology Societies 2012
One can prevent post-partum MS relapses by exclusive breast feeding: no.
Refining diagnosis of multiple sclerosis with revised MRI criteria.
A full genome search in multiple sclerosis.
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo

Pages